In conclusion, E-selectin acts as a homing receptor in the hematogenous dissemination of breast cancer [21], lung adenocarcinoma [22], prostate cancer [18], colon cancer [13] and pancreatic carcinoma cells [23]. The gene discussed is SELE; the disease is breast carcinoma.